Bruno B.

Accountable for the end-to-end lifecycle planning of a pipeline asset, from discovery through to market access strategy. Led the cross-functional development programme transitioning from late discovery into IND-enabling stages, progressing the lead asset toward its first GLP toxicology study in preparation for Phase 1 . Worked within a fast-moving R&D environment where scientific data and strategic priorities evolved, partnering with senior scientific stakeholders to maintain clear plans, defined milestones and aligned decision points. Introduced structured governance and regular review forums to improve visibility of progress, risks and interdependencies across the programme and wider portfolio.

Key Contributions

• Developed and maintained integrated programme plans, risk registers and decision logs, providing clear oversight across scientific, CMC, regulatory and external workstreams.

• Produced concise executive updates outlining key risks, trade-offs and recommended actions, informing quarterly portfolio-level decision-making.

• Reworked programme plans in response to evolving scientific data, maintaining delivery momentum and protecting critical development milestones.

• Strengthened coordination between scientific, regulatory and operational teams, reducing reactive escalations and improving predictability of key development milestones.

• Contributed to preparation of portfolio-level materials for senior leadership review forums, supporting strategic prioritisation discussions.

Provided delivery leadership for complex, cross-functional programmes within a regulated R&D environment, working across scientific, operational and external partner teams. Served as the primary delivery lead across scientific, operational and external partner teams, developing structured delivery plans, managing interdependencies and surfacing risks that could affect overall outcomes.

Key Contributions

• Led high-priority cross-functional workstreams in partnership with senior stakeholders and third-party providers, ensuring alignment on objectives, timelines and delivery constraints.

• Proactively identified and mitigated risks linked to vendor performance, resource limitations and external dependencies, preventing downstream delays to critical activities.

• Advised senior stakeholders on scope, timing and risk trade-offs, enabling timely decisions and protecting key development milestones.

• Strengthened programme reporting and communication frameworks, improving visibility of delivery status and emerging risks across teams.

Held overall responsibility for performance, compliance and service delivery within the Quality Control function in a regulated pharmaceutical testing laboratory setting. Managed the QC department while ensuring testing output met required quality, regulatory and client standards.

Improved predictability in laboratory delivery through stronger planning, resourcing and cross-functional coordination.

Key Contributions

• Acted as primary point of contact for clients and external partners, managing expectations around timelines, quality standards and issue resolution while maintaining delivery confidence.

• Strengthened planning and scheduling processes, improving reliability of testing turnaround times and overall resource utilisation within the team.

• Ensured sustained GMP compliance while delivering testing programmes to agreed timelines in a high throughput laboratory environment.

• Collaborated with QA, procurement and operations teams to resolve operational challenges and improve end-to-end service delivery.

• Led development and mentoring of laboratory staff, strengthening capability, accountability and consistency within the function.